Why the study?
QTc prolongation is associated with high all-cause mortality in hospitalized patients, but the differences in short- and long-term mortality after adjusting for comorbidity and main diagnosis remained unclear.
Does a prolonged QTc ≥500 ms predict increased short- and long-term mortality in hospitalized patients independent of comorbidities?
Does a prolonged QTc ≥500 ms predict increased short- and long-term mortality in hospitalized patients independent of comorbidities?
A prolonged QTc ≥500 ms is a powerful predictor of short-term mortality in hospitalized patients, independent of comorbidities.
Answers are grounded in this paper and cite their sources.
QTc ≥500 ms may flag high short- and long-term mortality risk in hospitalized patients; leaves open its added value after comorbidity adjustment.
AIMS: A prolonged corrected QT interval (QTc) ≥500 ms is associated with high all-cause mortality in hospitalized patients. We aimed to explore any difference in short- and long-term mortality in patients with QTc ≥500 ms compared with patients with QTc <500 ms after adjustment for comorbidity and main diagnosis. METHODS AND RESULTS: Patients with QTc ≥500 ms who were hospitalized at Telemark Hospital Trust, Norway between January 2007 and April 2014 were identified. Thirty-day and 3-year all-cause mortality in 980 patients with QTc ≥500 ms were compared with 980 patients with QTc <500 ms, matched for age and sex and adjusting for Charlson comorbidity index (CCI), previous admissions, and main diagnoses. QTc ≥500 ms was associated with increased 30-day all-cause mortality [hazard ratio (HR) 1.90, 95% confidence interval (CI) 1.38-2.62; P < 0.001]. There was no significant difference in mortality between patients with QTc ≥500 ms and patients with QTc <500 ms who died between 30 days and 3 years; 32% vs. 29%, P = 0.20. Graded CCI was associated with increased 3-year all-cause mortality (CCI 1-2: HR 1.62, 95% CI 1.34-1.96; P < 0.001; CCI 3-4: HR 2.50, 95% CI 1.95-3.21; P < 0.001; CCI ≥5: HR 3.76, 95% CI 2.85-4.96; P < 0.001) but was not associated with 30-day all-cause mortality. CONCLUSION: QTc ≥500 ms is a powerful predictor of short-term mortality overruling comorbidities. QTc ≥500 ms also predicted long-term mortality, but this effect was mainly caused by the increased short-term mortality. For long-term mortality, comorbidity was more important.
No takes yet. Share an insight, caveat, or question.
Gibbs et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: